Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/198520
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOhui, Kateryna-
dc.contributor.authorAfanasenko, Eleonora-
dc.contributor.authorBacher, Felix-
dc.contributor.authorTing, Rachel Lim Xue-
dc.contributor.authorZafar, Ayesha-
dc.contributor.authorBlanco-Cabra, Núria-
dc.contributor.authorTorrents Serra, Eduard-
dc.contributor.authorDömötör, Orsolya-
dc.contributor.authorMay, Nóra V.-
dc.contributor.authorDarvasiova, Denisa-
dc.contributor.authorEnyedy, Éva A.-
dc.contributor.authorPopović-Bijelić, Ana-
dc.contributor.authorReynisson, Jóhannes-
dc.contributor.authorRapta, Peter-
dc.contributor.authorBabak, Maria V.-
dc.contributor.authorPastorin, Giorgia-
dc.contributor.authorArion, Vladimir B.-
dc.date.accessioned2023-05-26T11:46:53Z-
dc.date.available2023-05-26T11:46:53Z-
dc.date.issued2019-01-24-
dc.identifier.issn0022-2623-
dc.identifier.urihttp://hdl.handle.net/2445/198520-
dc.description.abstractSix morpholine-(iso)thiosemicarbazone hybrids HL1-HL6 and their Cu(II) complexes with good-to-moderate solubility and stability in water were synthesized and characterized. Cu(II) complexes [Cu(L1-6)Cl] (1-6) formed weak dimeric associates in the solid state, which did not remain intact in solution as evidenced by ESI-MS. The lead proligands and Cu(II) complexes displayed higher antiproliferative activity in cancer cells than triapine. In addition, complexes 2-5 were found to specifically inhibit the growth of Gram-positive bacteria Staphylococcus aureus with MIC50 values at 2-5 μg/mL. Insights into the processes controlling intracellular accumulation and mechanism of action were investigated for 2 and 5, including the role of ribonucleotide reductase (RNR) inhibition, endoplasmic reticulum stress induction, and regulation of other cancer signaling pathways. Their ability to moderately inhibit R2 RNR protein in the presence of dithiothreitol is likely related to Fe chelating properties of the proligands liberated upon reduction.-
dc.format.extent19 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherAmerican Chemical Society-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1021/acs.jmedchem.8b01031-
dc.relation.ispartofJournal of Medicinal Chemistry, 2019, vol. 62, num. 2, p. 512-530-
dc.relation.urihttps://doi.org/10.1021/acs.jmedchem.8b01031-
dc.rightsCC BY (c) Ohui, Kateryna et al., 2019-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)-
dc.subject.classificationCèl·lules-
dc.subject.classificationInhibició-
dc.subject.classificationCàncer-
dc.subject.otherCells-
dc.subject.otherInhibition-
dc.subject.otherCancer-
dc.titleNew Water-Soluble Copper(II) Complexes with Morpholine-Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec696607-
dc.date.updated2023-05-26T11:46:54Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)
Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))

Files in This Item:
File Description SizeFormat 
696607.pdf5.78 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons